Bruce A Davidson
Overview
Explore the profile of Bruce A Davidson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schmitt R, Davidson B, He D, He G, Bulmahn J, Sambhara S, et al.
Nanomedicine (Lond)
. 2025 Mar;
:1-9.
PMID: 40079152
Background: Nanomedicine offers a number of innovative strategies to address major public health burdens, including complex respiratory illnesses. In this work, we introduce a multi-drug nanoparticle fabricated using femtosecond laser...
2.
Yang Q, Davidson B, Pajic P, Chen X, Gokcumen O, Gao M, et al.
Nucleic Acids Res
. 2025 Mar;
53(5).
PMID: 40037714
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus-like particles (VLPs) are ∼100-nm-sized bioinspired mimetics of the authentic virus. We undertook molecular engineering to optimize the VLP platform for messenger RNA...
3.
Marecki E, Oh K, Knight P, Davidson B
Biomicrofluidics
. 2024 Sep;
18(5):051503.
PMID: 39296325
Nanoparticles can be used for drug delivery and consist of many sizes and chemical compositions. They can accommodate a diverse population of drugs and can be made to target specific...
4.
Sia Z, Roy J, Huang W, Song Y, Zhou S, Luo Y, et al.
Cell Rep Med
. 2024 Feb;
5(3):101433.
PMID: 38401547
Inclusion of defined quantities of the two major surface proteins of influenza virus, hemagglutinin (HA) and neuraminidase (NA), could benefit seasonal influenza vaccines. Recombinant HA and NA multimeric proteins derived...
5.
Sia Z, Chiem K, Huang W, Seffouh A, Teimouri Dereshgi A, Hogan T, et al.
J Virol
. 2022 Sep;
96(19):e0100622.
PMID: 36106872
Intranasal vaccination offers the potential advantage of needle-free prevention of respiratory pathogens such as influenza viruses with induction of mucosal immune responses. Optimal design of adjuvants and antigen delivery vehicles...
6.
Kumar A, Kumari R, Liu T, Cao W, Davidson B, Knight P, et al.
Crit Rev Immunol
. 2022 Apr;
41(3):57-82.
PMID: 35378011
Influenza is a highly contagious respiratory virus that causes mild to severe respiratory illness, as well as death, and remains a serious threat to human health. Annual vaccination is the...
7.
Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al.
Adv Sci (Weinh)
. 2021 Jun;
8(16):e2100693.
PMID: 34189857
Influenza infections cause several million cases of severe respiratory illness, hospitalizations, and hundreds of thousands of deaths globally. Secondary infections are a leading cause of influenza's high morbidity and mortality,...
8.
Sia Z, He X, Zhang A, Ang J, Shao S, Seffouh A, et al.
Proc Natl Acad Sci U S A
. 2021 May;
118(22).
PMID: 34050027
Recombinant influenza virus vaccines based on hemagglutinin (HA) hold the potential to accelerate production timelines and improve efficacy relative to traditional egg-based platforms. Here, we assess a vaccine adjuvant system...
9.
Joma B, Siwapornchai N, Vanguri V, Shrestha A, Roggensack S, Davidson B, et al.
Infect Immun
. 2021 May;
89(8):e0047120.
PMID: 34031128
Streptococcus pneumoniae (pneumococcus) resides asymptomatically in the nasopharynx (NP) but can progress from benign colonizer to lethal pulmonary or systemic pathogen. Both viral infection and aging are risk factors for...
10.
Li F, Zou Y, Han M, Foyevtsova K, Shin H, Lee S, et al.
Sci Adv
. 2021 Feb;
7(2).
PMID: 33523988
Titanium monoxide (TiO), an important member of the rock salt 3d transition-metal monoxides, has not been studied in the stoichiometric single-crystal form. It has been challenging to prepare stoichiometric TiO...